Evoke Pharma, Inc. EVOK
Set alert
11.00 USD 0.00 0.00%
At close · Dec 17
11.00 0.00 -0.00%
After hours · Dec 17, 4:00 PM ET
11.00 Day range 11.00
3.54 52-week range 14.04
- YTD
- +148.87%
- 1 year
- +139.65%
- Open
- 11.00
- Prev close
- 11.00
- Mkt cap
- 7.37M
- Vol
- 47.10K
- Avg vol
- 395.00K
- EPS
- -10.13
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 11.00
- High
- 11.00
- Forward P/E
- 10.33
- Beta
- 0.35
- Short ratio
- 0.24
- Inst. own
- 17.13%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.97
- 200-d avg
- 5.60
- 1y target
- 18.00
2Y chart
Events in this range
- Mar 14, 2024Earnings: -7.08; estimate 0; surprise —%
- May 14, 2024Earnings: -2.04; estimate 0; surprise —%
- Aug 1, 2024Split: 1 for 12
- Aug 13, 2024Earnings: -0.93; estimate 0; surprise —%
- Nov 7, 2024Earnings: -0.94; estimate 0; surprise —%
Signals (78)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 24, 2025 | 11 months ago |
| SMA: Bullish | Nov 4, 2025 | 12 months ago |
| RSI: Overbought | Nov 4, 2025 | 12 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Oct 29, 2025 | 1 year ago |
| SMA: Bearish | Oct 28, 2025 | 1 year ago |
| SMA: Bullish | Oct 27, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 21, 2025 | 1 year ago |
| SMA: Bearish | Sep 24, 2025 | 1 year ago |
| SMA: Bullish | Sep 19, 2025 | 1 year ago |
| SMA: Bearish | Sep 17, 2025 | 1 year ago |
| SMA: Bullish | Sep 16, 2025 | 1 year ago |
| SMA: Bearish | Sep 15, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 25, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 18, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 13, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 5, 2025 | 1 year ago |
| SMA: Bullish | Aug 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 1, 2025 | 1 year ago |
| SMA: Bearish | Jul 31, 2025 | 1 year ago |
| SMA: Bearish | Jul 29, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 22, 2025 | 1 year ago |
| SMA: Bullish | Jul 9, 2025 | 1 year ago |
| SMA: Bullish | Jul 9, 2025 | 1 year ago |
| RSI: Overbought | Jul 9, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 8, 2025 | 1 year ago |
| SMA: Bearish | Jun 13, 2025 | 1 year ago |
| SMA: Bullish | Jun 11, 2025 | 1 year ago |
| SMA: Bearish | Jun 10, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 4, 2025 | 1 year ago |
| RSI: Overbought | May 22, 2025 | 1 year ago |
| SMA: Bullish | May 5, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 10, 2025 | 1 year ago |
| RSI: Oversold | Mar 18, 2025 | 1 year ago |
| RSI: Oversold | Mar 3, 2025 | 1 year ago |
| SMA: Bearish | Feb 28, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 24, 2025 | 1 year ago |
| SMA: Bearish | Feb 21, 2025 | 1 year ago |
| SMA: Bullish | Feb 13, 2025 | 1 year ago |
| SMA: Bullish | Jan 29, 2025 | 1 year ago |
| SMA: Bearish | Jan 28, 2025 | 1 year ago |
| SMA: Bullish | Jan 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 3, 2025 | 1 year ago |
| SMA: Bullish | Dec 19, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 12, 2024 | 1 year ago |
| SMA: Bearish | Nov 12, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 5, 2024 | 1 year ago |
| SMA: Bearish | Oct 31, 2024 | 2 years ago |
| SMA: Bullish | Oct 28, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 28, 2024 | 2 years ago |
| RSI: Overbought | Oct 28, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 23, 2024 | 2 years ago |
| SMA: Bullish | Oct 2, 2024 | 2 years ago |
| SMA: Bearish | Sep 27, 2024 | 2 years ago |
| SMA: Bullish | Sep 26, 2024 | 2 years ago |
| SMA: Bearish | Sep 24, 2024 | 2 years ago |
| SMA: Bullish | Sep 23, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 12, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 21, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 12, 2024 | 2 years ago |
| SMA: Bearish | Jul 22, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 19, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 9, 2024 | 2 years ago |
| SMA: Bullish | Jul 2, 2024 | 2 years ago |
| SMA: Bearish | Jul 1, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 27, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 21, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 20, 2024 | 2 years ago |
| SMA: Bullish | Jun 17, 2024 | 2 years ago |
| SMA: Bearish | Jun 14, 2024 | 2 years ago |
| SMA: Bullish | Jun 3, 2024 | 2 years ago |
| MACD: Buy Signal | May 1, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 9, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 28, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 20, 2024 | 2 years ago |
| RSI: Oversold | Jan 22, 2024 | 2 years ago |
| RSI: Oversold | Jan 17, 2024 | 2 years ago |
Key statistics
- Market cap
- 7.37M
- Enterprise value
- 1.20M
- Trailing P/E
- 0.00
- Forward P/E
- 10.33
- PEG ratio
- 0.00
- Price / sales
- 0.86
- Price / book
- 1.01
- EPS (TTM)
- -10.13
- Beta
- 0.35
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -71.33%
- Revenue (TTM)
- 8.62M
- Revenue growth
- 69.80%
- Free cash flow
- -1.49M
- Total cash
- 11.34M
- Total debt
- 5.00M
- Return on equity
- -349.91%
- Shares outstanding
- 1.49M
- Short % of float
- 1.70%
- 50-day average
- 4.97
- 200-day average
- 5.60
Analyst view
Consensus: none
Price target (mean) 18.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.63.
Financials — quick view
EVOK Revenue — quarterly 4.28M
EVOK Net income — quarterly -1.16M
EVOK EPS — quarterly -0.45
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | 0.00 | -0.94 | — | — |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | -0.93 | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.00 | -2.04 | — | — |
| Mar 14, 2024 | Dec 1, 2023 | 0.00 | -7.08 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | -6.12 | — | — |
| Aug 10, 2023 | Jun 1, 2023 | 0.00 | -6.72 | — | — |
About Evoke Pharma, Inc.
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- evokepharma.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on EVOK — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AIGH Capital Management LLC | 4.75% | 70,546 | 349.91K | Sep 29, 2024 |
| Bleichroeder LP | 4.63% | 68,750 | 341.00K | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 3.79% | 56,249 | 279.00K | Sep 29, 2024 |
| Corsair Capital Management, L.P. | 0.79% | 11,667 | 57.87K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.05% | 816 | 4.05K | Sep 29, 2024 |
| Blackrock Inc. | 0.01% | 122 | 605 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.17% | 2,487 | 12.34K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.16% | 2,404 | 11.92K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.10% | 1,496 | 7.42K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.03% | 373 | 1.85K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.00% | 41 | 203 | Oct 30, 2024 |